ENDOCRINE THERAPY OF PROSTATE-CANCER - OPTIMAL FORM AND APPROPRIATE TIMING

被引：49

作者：

CRAWFORD, ED ^{[1
]}

DEANTONIO, EP ^{[1
]}

LABRIE, F ^{[1
]}

SCHRODER, FH ^{[1
]}

GELLER, J ^{[1
]}

机构：

[1] UNIV COLORADO, DENVER, CO 80202 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1995年 / 80卷 / 04期

关键词：

D O I：

10.1210/jc.80.4.1062

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1062 / 1066

页数：5

共 44 条

[21]

EISENBERGER MA, 1994, SEMIN ONCOL, V21, P613

[22]

FRANSWORTH WE, 1976, ENDOCR RES COMMUN, V3, P105

[23]

GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440

[24]

GRAYHACK JT, 1969, JAMA-J AM MED ASSOC, V210, P1075

[25] STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN-VIVO AND IN-VITRO [J].

HARPER, ME ;

PIKE, A ;

PEELING, WB ;

GRIFFITHS, K .

JOURNAL OF ENDOCRINOLOGY, 1974, 60 (01) :117-+

[26] BILATERAL ADRENALECTOMY IN PROSTATIC CANCER - CLINICAL FEATURES AND URINARY EXCRETION OF 17-KETOSTEROIDS AND ESTROGEN [J].

HUGGINS, C ;

SCOTT, WW .

ANNALS OF SURGERY, 1945, 122 (06) :1031-1041

[27]

Huggins C, 1941, CANCER RES, V1, P293

[28] ORCHIECTOMY AND NILUTAMIDE OR PLACEBO AS TREATMENT OF METASTATIC PROSTATIC-CANCER IN A MULTINATIONAL DOUBLE-BLIND RANDOMIZED TRIAL [J].

JANKNEGT, RA ;

ABBOU, CC ;

BARTOLETTI, R ;

BERNSTEINHAHN, L ;

BRACKEN, B ;

BRISSET, JM ;

DASILVA, FC ;

CHISHOLM, G ;

CRAWFORD, ED ;

DEBRUYNE, FMJ ;

DIJKMAN, GD ;

FRICK, J ;

GOEDHALS, L ;

KNONAGEL, H ;

VENNER, PM .

JOURNAL OF UROLOGY, 1993, 149 (01) :77-83

[29]

Kozlowski JM, 1991, ADULT PEDIATRIC UROL, P1277

[30]

KRIEG M, 1979, J STEROID BIOCHEM, V11, P615, DOI 10.1016/0022-4731(79)90090-6

← 1 2 3 4 5 →